Your fact-checks will appear here
Studies on the effectiveness of COVID-19 vaccines
COVID-19 vaccines have been highly effective at preventing severe disease and death across studies, while protection against infection and symptomatic disease has been lower and wanes over months, esp...
Ivermectin dosing for human parasitic infections is weight-based and generally expressed in micrograms per kilogram (mcg/kg); the usual therapeutic range for common infections is about 150–200 mcg/kg ...
Clinical studies that describe "chronic" ivermectin use do not have a single standardized threshold; in the human trials reviewed, most chronic-use patterns meant multi-day or repeated dosing (for exa...
COVID-19 vaccination reduces the risk of severe COVID-19 in people with diabetes — a group at higher baseline risk of hospitalization and death from infection — and is considered safe for most patient...
Ivermectin overdose in humans typically produces a mix of gastrointestinal, cardiovascular and neurologic symptoms — nausea, vomiting, diarrhea, low blood pressure, dizziness, ataxia, altered mental s...
Animal biodistribution studies of mRNA‑LNP and adenoviral COVID‑19 vaccine platforms show different patterns: preclinical data and regulatory summaries indicate mRNA‑LNP signal concentrates at the int...
Ivermectin is an antiparasitic medicine approved for specific human infections and widely used in veterinary medicine; its safety and dosing are established for those approved indications, not for vir...
Early news coverage, political statements and social-media dynamics converted a scientific question about SARS‑CoV‑2 origins into a politicized public contest, reshaping which hypotheses were treated ...
No completed or registered human clinical trials testing ivermectin specifically as a therapy for liver fibrosis or nonalcoholic fatty liver disease (NAFLD) are identified in the provided reporting; t...
Directly, ivermectin is an anthelmintic (anti‑parasite) drug, not an antibiotic, so taking it without a prescription is unlikely to create bacterial “antibiotic resistance” in the classic sense; howev...
Clinical research has tested ivermectin beyond its core approvals (onchocerciasis, strongyloidiasis, and topical formulations for rosacea/head lice) in a range of parasitic contexts — notably scabies,...
Observational comparisons of vaccinated and unvaccinated populations are fertile ground for misleading conclusions unless a range of methodological biases are actively sought and addressed; the litera...